Orchid Pharma’s arm gets nod to manufacture product ‘7 ACA’ with committed capacity

18 Jul 2022 Evaluate

Orchid Pharma’s wholly owned subsidiary in India namely ‘Orchid Bio-Pharma’ has received approval to manufacture the product ‘7 ACA’ with a committed capacity of 1000 Metric Tonne Per Annum. This approval will help the Company in backward integration, reduce dependency on sourcing from China and aid in improving margins.

Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.

Orchid Pharma Share Price

689.80 -16.95 (-2.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×